Diabetes Board decisions

The Veteran's claim for increased ratings of diabetic peripheral neuropathy has been remanded due to the need for further evaluation and consideration.

The Veteran's claims for service connection were reopened and granted, with an effective date of January 11, 2008.

The Board has granted the Veteran's claim for service connection for diabetes mellitus type II, finding that it is secondary to his service-connected knee disabilities and obstructive sleep apnea.

The Board denied earlier effective dates for service connection of Diabetes Mellitus type II, Bilateral Upper Extremity Peripheral Neuropathy, and Bilateral Lower Extremity Peripheral Neuropathy as the earliest date of claim is April 5, 2024.

The Veteran's appeals for service connection were denied, and the Board found no legal basis to award VA burial benefits or accrued benefits. The claim for accrued benefits is dismissed due to a conflict with another pending appeal.

The Board has remanded the claims for service connection for diabetes mellitus type II, benign essential hypertension, and coronary arteriosclerosis due to insufficient medical opinions. The AOJ must clarify which Memorandum contains the correct findings regarding the Veteran's exposure to herbicides agents during active service.

The Board denied service connection for type II diabetes mellitus, bladder cancer, Parkinson's disease, and hypertension as there was no persuasive evidence linking these conditions to the Veteran's active service or exposure to herbicide agents or jet fuel.

The Board has identified a duty to assist error that occurred prior to the March 2025 rating decision on appeal and has ordered a remand for an addendum opinion regarding the etiology of the Veteran's diabetes.

The Veteran's entitlement to an allowance for an automobile or other conveyance and adaptive equipment was denied, while his restoration of severed service connection benefits for prostate cancer was granted. The effective date is not specified.

The Board has remanded the Veteran's claims for service connection for dermatomyositis and diabetes mellitus due to insufficient evidence in the record. The case will be reviewed with a new examination that considers both the Veteran's service records and his exposure during military service.

The Veteran is granted SMC at the rate authorized under 38 U.S.C. § 1114(m)(1/2) based on his service-connected disabilities, including Porphyria cutanea tarda with chronic urticaria and non-thrombocytopenia purpura (60% rating), Insomnia Disorder Associated with Tinnitus (50% rating), and Diabetes Mellitus (DM) with erectile dysfunction; back, gout associated with DM; left ankle gout, associated with DM; and right ankle gout, associated with DM (50% rating).

The Board has remanded the claims for effective dates prior to June 22, 2000, and February 16, 2001, for service connection of coronary artery disease (CAD) and diabetes mellitus, type II, respectively. The reasons are that VA treatment records dated from November 14, 1998, to June 21, 2000, and private treatment records pertaining to the Veteran's May 2000 emergency room visit have not been obtained.

The Veteran's appeals for increased ratings for right and left lower extremity diabetic peripheral neuropathy, as well as PTSD prior to January 10, 2022, have been REMANDED by the Board. Separate ratings or ratings for neuralgia are not warranted.,The Veteran's appeal for special monthly compensation based on housebound status is also REMANDED.

The Board has decided to remand the case due to a duty-to-assist error, requiring an additional medical opinion on whether the Veteran's service-connected sleep apnea caused his type II diabetes mellitus.

The Board has granted an effective date of November 3, 2020 for the award of service connection for various conditions including coronary artery disease, diabetes mellitus, and peripheral neuropathy. The decision is based on herbicide exposure during service in Thailand as per the PACT Act.

The Veteran's bilateral upper extremity diabetic neuropathy is rated at 50 percent since July 25, 2019. The rating for left lower extremity diabetic neuropathy prior to May 21, 2019, was denied.

The Veteran withdrew her appeal for service connection for deep vein thrombosis, diabetes mellitus, and hypothyroidism.

The Board denied service connection for diabetes mellitus and ischemic heart disease, finding no evidence of in-service exposure to herbicide agents or other causative events.

The Veteran's claims for service connection for various conditions have been granted. The claim for secondary service connection for hypertension is remanded.

The Veteran's type II diabetes mellitus and hypothyroidism were not shown to be related to his active duty service, and the Board denied service connection for both conditions.